Neuromelanin‐Sensitive MRI as a Marker of Clinical Severity and Disease Burden in Parkinson's Disease: A Systematic Review and Meta‐analysis
Movement Disorders, EarlyView.
Reader summaries
No reader summary yet. Contribute one with Claude — it takes a minute.